| Předmět: |
|
| Zdroj: |
Clinical Trials Week; 10/16/2023, p93-93, 1p |
| Abstrakt: |
By providing scientific data on whether commonly used drugs like paracetamol and ibuprofen can contribute to sepsis treatment, it may enhance the more effective management of patients. Keywords: Acetaminophen Therapy; Acetanilides; Analgesic Agents; Anilides; Antiinflammatory Agents; Blood Diseases and Conditions; Blood Diseases and Conditions - Sepsis; Bloodstream Infection; Clinical Research; Clinical Trials and Studies; Drugs and Therapies; Health and Medicine; Hospitals; Ibuprofen Therapy; Paracetamol Therapy; Pharmaceuticals; Phenylpropionates; Sepsis; Septicemia EN Acetaminophen Therapy Acetanilides Analgesic Agents Anilides Antiinflammatory Agents Blood Diseases and Conditions Blood Diseases and Conditions - Sepsis Bloodstream Infection Clinical Research Clinical Trials and Studies Drugs and Therapies Health and Medicine Hospitals Ibuprofen Therapy Paracetamol Therapy Pharmaceuticals Phenylpropionates Sepsis Septicemia 93 93 1 10/16/23 20231016 NES 231016 2023 OCT 19 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Trials Week -- Staff editors report on the newly launched clinical trial, NCT06061575, which has the following summary description: "This is a randomized double-blind controlled study with the primary aim of scientifically evaluating the potential effects of paracetamol and ibuprofen in the management of sepsis by comparing their fever-reducing efficacy in septic patients. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
